Search Results
Dr. Michael Birrer Treatments Targeting Either VEGF or ANG2 in Gynecologic Cancers
Prospects for Targeted Therapy in Ovarian Cancer - by Michael Birrer, MD, PhD
Dr. Birrer on Other Targets in Ovarian Cancer
Dr. Michael Birrer on Bevacizumab in Ovarian Cancers
Dr. Birrer on the Need for Novel Treatment Options in Cervical Cancer
Dr. Birrer on Challenges With Patient Demographics in Cervical Cancer
Michael J. Birrer, MD, PhD, on the role of maintenance therapy in newly diagnosed ovarian cancer
Michael Birrer on Predicting Outcomes in Ovarian Cancer
Michael J. Birrer, MD, PhD, regarding BRCA status in newly diagnosed ovarian cancer
Dr. Gershenson on Evolution of Targeted Therapies for Rare Gynecologic Malignancies
Michael J. Birrer, MD, PhD, elaborates on the outcomes from the FORWARD I study
Choosing Between VEGF and EGFR Targeted Therapy in mCRC
